Product Information
CYCLOSPORINE MODIFIED 50 MG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7676 per EA under NDC 00093901965. Its NADAC has been published 257 times since Jul 28, 2021.
Strength
50 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093901965
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CYCLOSPORINEApproval Type
Generic (ANDA)
FDA Application
ANDA065110On Market Since
6/8/2021
Pharmacological Classes
Price Statistics
The NADAC for CYCLOSPORINE MODIFIED 50 MG has been published 257 times since Jul 28, 2021, and over the history we have for it it has declined 32.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7676 per EA |
|---|---|
| All-time high | $1.3444 (Jun 15, 2022) |
| All-time low | $0.6456 (Mar 18, 2026) |
| 52-week high | $1.0011 |
| 52-week low | $0.6456 |
| Median price | $1.0708 |
| Average price | $1.0417 |
| Largest weekly change | -36.2% (Nov 20, 2024) |
| Weeks tracked | 257 |
| Tracking since | Jul 28, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CYCLOSPORINE MODIFIED 50 MG?
The current National Average Drug Acquisition Cost (NADAC) for CYCLOSPORINE MODIFIED 50 MG, manufactured by Teva Pharmaceuticals USA Inc., is $0.7676 per EA (NDC 00093901965), effective Jun 24, 2026.
How has the price of CYCLOSPORINE MODIFIED 50 MG changed over time?
Over the history we have for it, the NADAC for CYCLOSPORINE MODIFIED 50 MG has declined 32.8%. It has been tracked across 257 weekly CMS publications since Jul 28, 2021.
What are the highest and lowest recorded NADAC prices for CYCLOSPORINE MODIFIED 50 MG?
Since Jul 28, 2021, the NADAC for CYCLOSPORINE MODIFIED 50 MG has ranged from a low of $0.6456 (Mar 18, 2026) to a high of $1.3444 (Jun 15, 2022), with a median of $1.0708 per EA.
Are there cheaper alternatives to CYCLOSPORINE MODIFIED 50 MG?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as CYCLOSPORINE MODIFIED 50 MG, but none are currently priced below it.
Who manufactures CYCLOSPORINE MODIFIED 50 MG?
CYCLOSPORINE MODIFIED 50 MG (NDC 00093901965) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification